| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |